Ionis Pharmaceuticals' Patient Advocacy Organization Sponsorship Program supports not-for-profit groups advancing education, peer support, and awareness for serious and rare diseases.
Ionis Pharmaceuticals' Investigator‑Initiated Research Program funds independent studies advancing science in cardiovascular, hereditary angioedema, and neurological diseases.
Independent Medical and Patient Education/Advocacy Grants support organizations’ medical education, patient awareness, advocacy, and conference travel initiatives to advance knowledge and improve patient care.
Alnylam Pharmaceuticals' Sponsorships fund educational and scientific initiatives advancing research and awareness in ATTR amyloidosis, AHP, and PH1.
Responses to Requests for Proposals supports organizations delivering independent education for healthcare professionals and patients to address knowledge gaps and improve care in ATTR amyloidosis, AHP, and PH1.
Patient Education Grants support nonprofit patient advocacy organizations providing unbiased, non-promotional education for patients, caregivers, and the public to meet patient needs through education and support.